🔎 Trials Near Me

Início › Leucemia Linfoblástica Aguda › Carolina do Norte

Ensaios clínicos de Leucemia Linfoblástica Aguda em Carolina do Norte

21 estudos para Leucemia Linfoblástica Aguda estão buscando participantes em locais em Carolina do Norte.

Cidades em Carolina do Norte

Texto oficial do estudo (Inglês)

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

  • AdventHealth Infusion Center Asheville, Asheville
  • Southeastern Medical Oncology Center-Clinton, Clinton
  • AdventHealth Infusion Center Haywood, Clyde
  • e mais 6
RecrutandoEstudo observacionalVoluntários saudáveis bem-vindos
Idades de 40 a 75 · Todos os sexos · Atualizado em 2 de out. de 2026 · NCT05334069

A Study of Revumenib in R/R Leukemias Including Those With an MLL/KMT2A Gene Rearrangement or NPM1 Mutation

  • Duke University Medical Center, Durham
RecrutandoFase 1/2
30 Days · Todos os sexos · Atualizado em 16 de set. de 2026 · NCT04065399

The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study

  • Mission Hospital, Asheville
  • UNC Lineberger Comprehensive Cancer Center, Chapel Hill
  • Carolinas Medical Center/Levine Cancer Institute, Charlotte
  • e mais 4
RecrutandoFase 1/2
Até 22 anos · Todos os sexos · Atualizado em 25 de ago. de 2026 · NCT04726241

Caloric Restriction and Activity to Reduce Chemoresistance in B-ALL

  • Levine Children's Hospital, Charlotte
RecrutandoFase 2
Idades de 7 a 25 · Todos os sexos · Atualizado em 19 de ago. de 2026 · NCT05082519

Strength Training Exercise in Pediatric Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma (STEP-ALL)

  • University of North Carolina at Chapel Hill, Lineberger Comprehensive Cancer Center, Chapel Hill
RecrutandoVoluntários saudáveis bem-vindos
Idades 6 e acima · Todos os sexos · Atualizado em 3 de ago. de 2026 · NCT07634653

Study of AZD3632 Monotherapy or in Combination With Anticancer Agents in Participants With Advanced Haematologic Malignancies With KMT2Ar, NPM1m, or Other Genotypes Associated With HOX Overexpression

  • Research Site, Chapel Hill
  • Research Site, Durham
RecrutandoFase 1/2
Idades 16 e acima · Todos os sexos · Atualizado em 20 de jul. de 2026 · NCT07155226

Therapy for Newly Diagnosed Patients With B-Cell Precursor Acute Lymphoblastic Leukemia and Lymphoma

  • Novant Health Presbyterian Hemby Children's Hospital, Charlotte
RecrutandoFase 2
Idades de 1 a 18 · Todos os sexos · Atualizado em 16 de jul. de 2026 · NCT06533748

Identification of Necessary Information for Treatment Induction in Newly Diagnosed Acute Lymphoblastic Leukemia/Lymphoma

  • Novant Health Presbyterian Hemby Children's Hospital, Charlotte
RecrutandoFase 4
Idades de 1 a 18 · Todos os sexos · Atualizado em 14 de jul. de 2026 · NCT06289673

A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)

  • University of North Carolina at Chapel Hill, Chapel Hill
  • Levine Children's Hospital, Charlotte
  • Duke University Medical Center, Durham
RecrutandoEstudo observacional
Todas as idades · Todos os sexos · Atualizado em 6 de jul. de 2026 · NCT01351545

Registry of Older Patients With Cancer

  • Seby B. Jones Cancer Center, Boone
  • Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill, Chapel Hill
  • East Carolina University, Greenville
  • e mais 4
RecrutandoEstudo observacional
Idades 65 e acima · Todos os sexos · Atualizado em 29 de jun. de 2026 · NCT01137825

A Study of Revumenib and Mezigdomide in People With Leukemia

  • University of North Carolina (Data Collection Only), Chapel Hill
RecrutandoFase 1/2
Idades 12 e acima · Todos os sexos · Atualizado em 22 de jun. de 2026 · NCT07356154

TINI 2: Total Therapy for Infants With Acute Lymphoblastic Leukemia II

  • Novant Health - Hemby Children's Hospital, Charlotte
RecrutandoFase 1/2
Até 1 anos · Todos os sexos · Atualizado em 3 de jun. de 2026 · NCT05848687

Study of CM4620 to Reduce the Severity of Pancreatitis Due to Asparaginase

  • Novant Health Presbyterian Hemby Children's Hospital, Charlotte
RecrutandoFase 1/2
Até 21 anos · Todos os sexos · Atualizado em 3 de jun. de 2026 · NCT04195347

Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment

  • Mission Hospital, Asheville
  • Wake Forest University Health Sciences, Winston-Salem
RecrutandoEstudo observacional
Todas as idades · Todos os sexos · Atualizado em 18 de mai. de 2026 · NCT01790152

Study of Oral Administration of LP-118 in Patients With Relapsed or Refractory CLL, SLL, MDS, MDS/MPN, AML, CMML-2, MPN-BP, ALL, MF, NHL, RT, MM or T-PLL.

  • University of North Carolina, Chapel Hill
RecrutandoFase 1
Idades 13 e acima · Todos os sexos · Atualizado em 5 de mai. de 2026 · NCT04771572

The Prospective Collection, Storage and Reporting of Data on Patients Undergoing Hematopoietic Stem Cell Transplantation Utilizing a Standard Preparative Regimen

  • Wake Forest Baptist Health, Winston-Salem
RecrutandoEstudo observacional
Idades de 18 a 120 · Todos os sexos · Atualizado em 13 de abr. de 2026 · NCT01890486

A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)

  • UNC Hospital, Chapel Hill
  • Duke University, Durham
  • Atrium Wake Forest Baptist Medical Center, Winston-Salem
RecrutandoFase 1/2
Idades 12 e acima · Todos os sexos · Atualizado em 24 de mar. de 2026 · NCT04988555

Pharmacokinetics of Drugs Administered to Children

  • Duke University, Durham
RecrutandoEstudo observacional
Idades de 0 a 20 · Todos os sexos · Atualizado em 7 de jan. de 2026 · NCT03481881

Tissue, Blood, and Body Fluid Sample Collection From Patients With Hematologic Cancer

  • Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill, Chapel Hill
RecrutandoEstudo observacional
Idades de 18 a 120 · Todos os sexos · Atualizado em 27 de out. de 2025 · NCT01137643

Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies

  • Carolina-Levine Children's Hospital, Charlotte
RecrutandoFase 1
Idades de 1 a 21 · Todos os sexos · Atualizado em 6 de dez. de 2024 · NCT05476770

Fonte: ClinicalTrials.gov, dados obtidos em 5 de out. de 2026. Cada estudo define seus próprios critérios de elegibilidade; a equipe do estudo decide quem pode participar.